Effective on February 20, 2015, Sunshine Biopharma, Inc. announced that Michele Di Turi resigned as Chief Operating Officer and a Director of the company. Also on February 20, 2015, to replace Mr. Di Turi, Dr. Abderrazzak Merzouki was appointed as Chief Operating Officer and a Director of company pursuant to the provisions of Bylaws, to hold such office until the
next annual meeting of shareholders, his resignation, removal or death, whichever comes first. In addition to Merzouki, new positions with company, since January 2015 he has been self- employed as a consultant in the fields of biotechnology and pharmacology. From July 2007 through December 2014, Dr. Merzouki worked at the Institute of Biomedical Engineering in the Department of Chemical Engineering at Ecole Polytechnique de Montreal.